NEM

Wall Street Analysts' Outlook on Newmont

This morning we watched Newmont drop -4.2% to a price of $44.07 per share. The Large-Cap Silver company is now trading -26.21% below its average target price of $59.72. Analysts have set target prices ranging from $47.0 to $80.0 per share for Newmont, and have given the stock an average rating of buy.

Newmont's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.0%. The stock's short ratio is 2.22. At 0.09%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.

Another number to watch is the company's rate of institutional share ownership, which now stands at 74.1%. In conclusion, we believe there is mixed market sentiment regarding Newmont.

Institutions Invested in Newmont

Date Reported Holder Percentage Shares Value
2024-06-30 Vanguard Group Inc 12% 135,010,500 $5,949,912,693
2024-06-30 Blackrock Inc. 10% 119,250,973 $5,255,390,343
2024-06-30 State Street Corporation 4% 50,606,358 $2,230,222,181
2024-09-30 Van Eck Associates Corporation 4% 48,950,153 $2,157,233,227
2024-06-30 Bank Of New York Mellon Corporation 2% 23,209,649 $1,022,849,224
2024-06-30 Geode Capital Management, LLC 2% 23,158,139 $1,020,579,178
2024-06-30 First Eagle Investment Management, LLC 2% 17,108,828 $753,986,044
2024-06-30 Norges Bank Investment Management 1% 16,587,209 $730,998,295
2024-06-30 Deutsche Bank Aktiengesellschaft 1% 14,493,193 $638,715,011
2024-06-30 Northern Trust Corporation 1% 11,978,009 $527,870,852
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS